Risperdal Consta Kit
Product Images NDC 50458-309

Product Visual Gallery

This gallery contains 31 technical images submitted to the FDA as part of the official labeling for Risperdal Consta (NDC 50458-309). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Janssen Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure (Risperdal 01)

Illustration showing components of the RISPERDAL CONSTA kit by Janssen Pharmaceuticals, Inc., including a vial adapter with Luer opening, spike tip, and skirt; a prefilled syringe with plunger rod, diluent, white collar, and cap; a vial containing microspheres with a colored cap; and two Terumo SurGuard 3 injection needles labeled for deltoid (1-inch) and gluteal (2-inch) use, featuring transparent needle protectors and needle safety devices.*

FDA Label Image

Figure (Risperdal 02)

Illustration depicting a rectangular kit box with a clock icon showing 30 minutes, indicating a time-related instruction or waiting period associated with the RISPERDAL CONSTA kit by Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 03)

An instructional illustration showing how to remove the protective cap from a vial. A hand is holding the vial while another hand is lifting the cap upwards and away from the vial.*

FDA Label Image

Figure (Risperdal 04)

An instructional diagram showing the preparation of the RISPERDAL CONSTA kit for administration. It depicts a hand holding the prefilled syringe or vial, removing or assembling components as part of the medication preparation process for risperidone injection.*

FDA Label Image

Figure (Risperdal 05)

An instructional diagram illustrating the proper way to press down on the cap of a vial or syringe component. The image highlights hand placement and applies downward pressure, as indicated by a bold arrow pointing downwards. This is typically part of the preparation process for a medication kit such as RISPERDAL CONSTA.*

FDA Label Image

Figure (Risperdal 06)

An instructional illustration showing a hand placing an ampule into a vial or bottle, demonstrating part of the preparation process for administration. This image is associated with RISPERDAL CONSTA, a risperidone kit by Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 07)

An instructional illustration showing a gloved hand holding a vial with a dropper or syringe above it, and an upward pointing arrow indicating an action to lift or pull upward. The image likely depicts a step in the preparation or handling of an injection kit.*

FDA Label Image

Figure (Risperdal 08)

Text panel from RISPERDAL CONSTA kit with instructions to remove the vial adapter from the sterile blister only when ready to remove the white cap from the prefilled syringe.*

FDA Label Image

Figure (Risperdal 09)

An illustration showing a hand holding a syringe. The image appears to demonstrate the proper way to hold or use the syringe, likely as part of administration instructions for the RISPERDAL CONSTA kit by Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 10)

An instructional illustration showing a hand holding a RISPERDAL CONSTA injection kit component, likely demonstrating how to grasp or prepare the medication for administration. The image focuses on the positioning of the fingers on the kit part.*

FDA Label Image

Figure (Risperdal 11)

An instructional illustration showing hands snapping two parts of a device or container together, with the text 'SNAP!' above the image, indicating the action to snap the parts into place. The image is likely part of usage directions for RISPERDAL CONSTA kit by Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 12)

An instructional illustration showing a syringe from the RISPERDAL CONSTA kit with the cap removed, displaying the syringe's appearance without the cap. The image is part of the kit's usage instructions provided by Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 13)

An instructional illustration showing the preparation of RISPERDAL CONSTA (risperidone) kit. The image depicts two hands holding a vial and a syringe; one hand pushes down on the syringe plunger while the other stabilizes the vial. An arrow indicates downward pressure, and a circular arrow suggests twisting motion, likely guiding medication withdrawal steps.*

FDA Label Image

Figure (Risperdal 14)

An instructional illustration showing a hand holding a syringe positioned above a vial, with an arrow pointing downward, indicating the syringe should be inserted into the vial. This graphic likely demonstrates the step of drawing medication from the vial as part of the preparation process for RISPERDAL CONSTA kit by Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 15)

A textual warning panel instructing that vial contents will now be under pressure and advising to keep holding the plunger rod down with the thumb. The text emphasizes safety handling directions but does not specify product name or dosage.*

FDA Label Image

Figure (Risperdal 16)

An instructional illustration showing a hand holding a syringe with an arrow indicating a 10-second pause during injection. The image is related to the preparation or administration of RISPERDAL CONSTA, a risperidone kit by Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 17)

An instructional illustration showing hands preparing a syringe by attaching a vial, likely demonstrating how to assemble the RISPERDAL CONSTA injection kit before administration.*

FDA Label Image

Figure (Risperdal 18)

An instructional illustration showing a hand holding a syringe with the needle covered, and another hand grasping a vial. An arrow indicates the vial should be twisted counterclockwise to open or prepare it for use. The image likely demonstrates part of the preparation process for administering a medication injection, such as a kit containing risperidone.*

FDA Label Image

Figure (Risperdal 19)

An instructional diagram showing two injection sites for RISPERDAL CONSTA kit. The left image indicates the deltoid muscle with a 1-inch needle, while the right image shows the gluteal muscle with a 2-inch needle. Each site is highlighted with corresponding needle length and color-coded labels.*

FDA Label Image

Figure (Risperdal 20)

An instructional illustration showing hands holding a syringe and a vial or cartridge, demonstrating the process of removing a protective cap by twisting it off. This diagram is likely part of the preparation or administration instructions for RISPERDAL CONSTA kit, containing risperidone.*

FDA Label Image

Figure (Risperdal 21)

An instructional illustration showing a hand gripping a syringe with arrows indicating an up-and-down motion. This likely demonstrates the technique for mixing or preparing a medication dose in a kit format.*

FDA Label Image

Figure (Risperdal 22)

An instructional diagram illustrating the use of a medical device, showing a lever being pulled back and an arrow indicating the direction of insertion of a component. Likely related to the assembly or administration process for RISPERDAL CONSTA kit by Janssen Pharmaceuticals.*

FDA Label Image

Figure (Risperdal 23)

An instructional illustration showing two hands preparing an injection syringe. One hand holds the syringe, while the other hand pulls back on the syringe plunger, with an upward arrow indicating the direction of movement. The syringe has a cap attached, suggesting preparation steps for administering an injectable medication kit.*

FDA Label Image

Figure (Risperdal 24)

An instructional illustration showing a human figure from the front with two arrows indicating specific injection sites, one at the upper arm and another at the buttock area. This diagram likely demonstrates recommended injection locations for administering a medication kit.*

FDA Label Image

Figure (Risperdal 25)

An instructional illustration showing a hand holding a vial and applying its contents onto a surface, with a close-up inset highlighting the application step labeled 'AFTER.' The image demonstrates part of the preparation or usage process for a dosage form, related to RISPERDAL CONSTA kit from Janssen Pharmaceuticals, Inc.*

FDA Label Image

Figure (Risperdal 26)

An instructional illustration showing a hand holding a syringe above an open sharps disposal container marked with a biohazard symbol. The image depicts safe needle disposal procedures.*

FDA Label Image

Chemical Structure (Risperdal 27)

Chemical structure of risperidone, the active ingredient in RISPERDAL CONSTA, shown as a molecular diagram with labeled atoms and bonds.*

FDA Label Image

Principal Display Panel (12.5 mg Kit Carton)

Risperdal Consta 12.5 mg dose pack kit by Janssen Pharmaceuticals, Inc. The label shows it contains risperidone long-acting injection microspheres for intramuscular use. The kit includes a vial of risperidone extended-release microspheres, a syringe with diluent, a vial adapter, and safety needles for deltoid and gluteal injections. Storage instructions advise refrigeration. The packaging highlights single-use and prescription status.*

FDA Label Image

Principal Display Panel (25 mg Kit Carton)

RISPERDAL CONSTA 25 mg Dose Pack by Janssen Pharmaceuticals, Inc. is shown in a flat carton layout. The kit contains risperidone extended-release microspheres for long-acting injection, including a vial, pre-filled syringe, vial adapter, and safety needles for deltoid or gluteal intramuscular injection. The packaging highlights storage in a refrigerator and instructions for healthcare professional administration.*

FDA Label Image

Principal Display Panel (37.5 mg Kit Carton)

Risperdal CONSTA 37.5 mg Dose Pack kit packaging label for risperidone long-acting injection by Janssen Pharmaceuticals, Inc. The label states contents include one 37.5 mg vial of extended-release microspheres, a pre-filled syringe with diluent, vial adapter, and safety needles for intramuscular injection. It indicates storage instructions and usage directions for healthcare professionals.*

FDA Label Image

Principal Display Panel (50 mg Kit Carton)

Flat packaging label for RISPERDAL CONSTA 50 mg Dose Pack by Janssen Pharmaceuticals, Inc., presenting a kit with risperidone long-acting injection. The label includes dosing instructions, kit contents such as a 50 mg vial, syringe, vial adapter, and safety needles, along with storage instructions to keep the package refrigerated. It is indicated for deltoid or gluteal intramuscular injection and notes that it is Rx only, single use.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.